Interferon Gamma-1B
Interferon Gamma-1B is a pharmaceutical drug with 23 clinical trials. Currently 2 active trials ongoing. Historical success rate of 70.0%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
10
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
70.0%
14 of 20 finished
30.0%
6 ended early
2
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
ACTIMMUNE in Intermediate Osteopetrosis
Clinical Trials (23)
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
ACTIMMUNE in Intermediate Osteopetrosis
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23